title: [Meningeal cryptococcosis as a sign of immune reconstitution syndrome].
authors.forename: Aída
authors.initials: A
authors.lastname: Martínez-Baltanás
authors.forename: José M
authors.initials: JM
authors.lastname: Cuadrado
authors.forename: Francisco
authors.initials: F
authors.lastname: Jover
authors.forename: Pablo
authors.initials: P
authors.lastname: Roig
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000209:etiology* / Q000276:immunology; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007156:Immunologic Memory / Q000187:drug effects*; D019259:Lamivudine / Q000009:adverse effects / Q000627:therapeutic use; D061466:Lopinavir; D008297:Male; D016919:Meningitis, Cryptococcal / Q000209:etiology* / Q000276:immunology; D011744:Pyrimidinones / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use; D013577:Syndrome; D016176:T-Lymphocyte Subsets / Q000276:immunology; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D000935:Antifungal Agents; D011744:Pyrimidinones; C068538:liposomal amphotericin B; D061466:Lopinavir; D019259:Lamivudine; D015215:Zidovudine; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine; D019438:Ritonavir